Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely recognized and utilized for their ability to decrease inflammation and swelling during the acute phase of various musculoskeletal and soft-tissue injuries.
The retrieved literature supports the well-established pharmacological role of NSAIDs in reducing inflammation and edema during the acute phase of musculoskeletal and neural injuries (such as tendinopathies and acute trauma). While papers [8] and [2] discuss potential adverse effects of NSAIDs in bone healing and renal function, they do not refute the fundamental pharmacological mechanism that NSAIDs decrease acute inflammation and swelling. The claim is therefore well supported by the provided evidence.